54 results
Page 2 of 3
8-K
EX-1.2
i6xq4rlsrvhr911v2md
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
8-K
EX-1.1
shban9cna3ah3f
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
424B5
ewmgkq
19 May 20
Prospectus supplement for primary offering
5:11pm
424B5
3xj3wpw4
19 May 20
Prospectus supplement for primary offering
5:08pm
424B5
93xljbpoija
18 May 20
Prospectus supplement for primary offering
4:16pm
424B5
1kas8mvscnufrauumra
18 May 20
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.1
d9b39vs
12 May 20
Gossamer Bio Announces First Quarter 2020 Financial Results and Provides Corporate Update
4:18pm
8-K
EX-99.1
e5v4c2
24 Mar 20
Gossamer Bio Announces Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update
8:45am
8-K
uqv6 dviszfk21ak
30 May 19
Departure of Directors or Certain Officers
8:00am
8-K
EX-10.1
n6z03ps0 3o8a9cf
3 May 19
Gossamer Bio Secures Debt Facility for Up to $150 Million
4:00pm
DEF 14A
qc47z9f 7ar1
30 Apr 19
Definitive proxy
4:04pm
10-K
8a7r4wx5
22 Mar 19
Annual report
4:45pm
424B4
mmulnq
8 Feb 19
Prospectus supplement with pricing info
4:40pm
CORRESP
hyc8chqn1m8
5 Feb 19
Correspondence with SEC
12:00am